NCT04304547 - Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

April 2, 2020

Study Completion Date

April 2, 2020

Conditions

Healthy

Interventions

DRUG

CKD-828, D097, D337, CKD-348 T1, CKD-348 T2

"Subject of sequence A takes IP in the following order:~1. Each tablet of CKD-828 and D097 and D337 be taken at once~2. CKD-348 T1 1 tablet~3. CKD-348 T2 1 tabet"

DRUG

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337,

"Subject of sequence B takes IP in the following order:~1. CKD-348 T1 1 tablet~2. CKD-348 T2 1 tablet~3. Each tablet of CKD-828 and D097 and D337 be taken at once"

DRUG

CKD-348 T2, CKD-348 T1, CKD-828, D097, D337

"Subject of sequence C takes IP in the following order:~1. CKD-348 T2 1 tablet~2. Each tablet of CKD-828 and D097 and D337 be taken at once~3. CKD-348 T1 1 tablet"

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam-si